FIELD: medicine.
SUBSTANCE: group of inventions relates to field of pharmaceutics and deals with aqueous composition, containing antibody and alkylglycoside, which has CNC value about 1.0 mM or higher in water at 25°C, where alkylglycoside is present in concentration, which is lower than alkylglycoside CMC value in water at 25°C. Also claimed are method of antibody aggregation inhibition and method for prevention of antibody oxidation in aqueous solution with application of aqueous composition.
EFFECT: increased antibody stability in therapeutically suitable compositions.
33 cl, 16 dwg, 2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITIONS AND METHODS USED FOR STABILISATION OF PROTEIN-CONTAINING FINISHED FORMS | 2011 |
|
RU2584232C2 |
STABLE ISOTONIC LYOPHILIZED PROTEIN COMPOSITION | 1996 |
|
RU2229288C2 |
STABLE ISOTONIC LYOPHILISED PROTEIN COMPOSITION | 1996 |
|
RU2497500C2 |
HIGHLY CONCENTRATED COMPOSITIONS OF ANTIBODIES AND PROTEINS | 2004 |
|
RU2332986C2 |
COMPOSITIONS CONTAINING ANTIBODY-DRUG CONJUGATES DUOCARMICIN | 2016 |
|
RU2687237C1 |
STABLE COMPOSITIONS OF IMMUNOCONJUGATES CONTAINING ANTIBODIES TO CD79b | 2019 |
|
RU2800803C2 |
PEPTIDE DRUGS WITH HIGH EFFECTIVENESS AGAINST INSULIN RESISTANCE | 2012 |
|
RU2602801C2 |
COMPOSITIONS FOR DRUG INTRODUCTION | 2009 |
|
RU2554814C2 |
COMPOSITION CONTAINING ANTIBODY | 2010 |
|
RU2609658C2 |
IMMUNOGLOBULIN COMPOSITIONS AND PRODUCTION PROCEDURE | 2004 |
|
RU2358763C2 |
Authors
Dates
2016-02-20—Published
2011-06-23—Filed